Macular DegenerationVision and hearing
What this study is
The purpose of this prospective study is to investigate whether ophthalmic artery stenosis (narrowing of the ophthalmic artery) contributes to the development and progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD).
Study details
- Sponsor
- Scott Raymond
- Conditions
- Macular Degeneration
- Enrolling
- 30 people
- Starts
- 2026-09-01
- Est. completion
- 2028-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 50 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- 50-80 years of age
- All genders
- Asymmetric dry AMD with geographic atrophy in at least one eye and reduced disease severity in the other eye according to International Classification of Disease (ICD) codes
- Treated at the Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
You can't join if
- Poor image quality that limits quantification
- GA extending beyond the borders of the SDOCT field of view.
- Bilateral symmetric geographic atrophy.
- Diagnosis of wet AMD.
- Any retinal fluid at baseline.
- Other concurrent retinal diseases
- Vitreoretinal surgery.
- Allergy to iodinated contrast agents.
- Chronic kidney disease with eGFR < 60
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openCleveland Clinic
Cleveland, Ohio, United States
- Sara Lautzenhiser Research Coordinator · Contact216-444-3026LAUTZES@ccf.org
- Scott Raymond, MD · Principal investigator
Recruiting
Study team
Sponsor
Scott Raymond
Study ID 26-465
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.